Neurodegenerative diseases (NDDs), which have no known cures and elusive causes, result in irreversible damage to the brain and nervous system. Research into these diseases typically focuses on the brain, but mouse studies ...
Jun 15, 2024
0
7
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are two devastating neurodegenerative diseases. Scientists have long suspected a protein called FUS might play a role, but the exact mechanism remained ...
Jun 14, 2024
0
14
Researchers worldwide can now create highly realistic brain cortical organoids—essentially miniature artificial brains with functioning neural networks—thanks to a proprietary protocol released this month by researchers ...
Jun 10, 2024
0
58
Amyotrophic lateral sclerosis (ALS) patients received better care if they were treated by a neurologist, a new study published in PLOS One has found.
Jun 10, 2024
0
0
Every year roughly 1,000 Canadians are diagnosed with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease). Some 4,000 Canadians are currently living with the disease.
May 14, 2024
0
0
Approximately 31,000 people are living with amyotrophic lateral sclerosis (ALS) in the United States, with an average of 5,000 new cases every year, according to the Centers for Disease Control and Prevention.
May 8, 2024
0
10
Researchers from Tokyo Metropolitan University have identified how proteins collect abnormally in neurons, a feature of neurodegenerative diseases like Alzheimer's. The research is published in the journal eLife.
Apr 22, 2024
0
72
An opinion paper published by University of Montana professor Lilian Calderón-Garcidueñas MD, Ph.D. and co-authors, Dr. Alberto Ayala and Dr. Partha Mukherjee discussed ow US citizens are not fully aware of the harmful ...
Apr 5, 2024
0
1
Changes in personality, behavior and language are hallmarks of frontotemporal dementia (FTD), the most common form of dementia in patients under the age of 65, which is associated with degeneration of the frontal and temporal ...
Apr 5, 2024
0
72
Amylyx Pharmaceuticals announced Thursday it was withdrawing its approved treatment against the deadly neurodegenerative disease ALS after clinical data found no evidence the drug worked.
Apr 4, 2024
0
1
